联环药业龙虎榜数据（8月21日）

Group 1 - The stock of Lianhuan Pharmaceutical (600513) experienced a limit down today, with a turnover rate of 21.27% and a trading volume of 1.644 billion yuan, showing a fluctuation of 11.46% [1] - The stock was listed on the Shanghai Stock Exchange due to a daily decline deviation of -10.13%, with a net selling amount of 44.7459 million yuan from brokerage seats [2] - In the past six months, the stock has appeared on the龙虎榜 (Dragon and Tiger List) nine times, with an average price increase of 2.65% the day after being listed and an average increase of 8.92% over the following five days [3] Group 2 - For Q1, Lianhuan Pharmaceutical reported a revenue of 628 million yuan, representing a year-on-year growth of 18.78%, while net profit was 23.0596 million yuan, a year-on-year decline of 29.15% [4] - The company issued a half-year performance forecast on July 15, expecting a net loss between 45 million yuan and 38 million yuan, indicating a year-on-year change range of -171.56% to -160.42% [5] - The top buying brokerage on August 21 was Guotai Junan Securities, with a purchase amount of 74.1533 million yuan, while the top selling brokerage was CITIC Securities, with a selling amount of 55.9735 million yuan [5]